Given the current situation, Vitalgaia wants to enhance its product by exploring its effectiveness against COVID-19. Firstly, it is important to highlight the viricidal activity of propolis and carnosic acid, verified by numerous research groups against several virus: HSV, VSV, avian reovirus, IBDV, IAV. Furthermore, VG-01 could strengthen the immune system and attenuate the progression of inflammation. Additionally, Epigallocatechin gallate (EGCG) a propolis compound has a strong affinity towards virus proteins.
Moreover, during the COVID-19 co-treatment, nosocomial infections can appear facilitating the entry of other pathogens: bacteria and fungi that flood the alveoli and other vital organs leading to a multi-organic failure and death.